In order to use RunSignup, your browser must accept cookies. Otherwise, you will not be able to register for races or use other functionality of the website. However, your browser doesn't appear to allow cookies by default.
If you still see this message after clicking the link, then your browser settings are likely set to not allow cookies. Please try enabling cookies. You can find instructions at https://www.whatismybrowser.com/guides/how-to-enable-cookies/auto.
Thank you to all who participated in the 8th Annual PCS 5K! Together we raised over $140,000 for sarcoma research and awareness.
Registration will open in January 2019.
If you have any questions about this race, click the button below.Questions?
In January 2011, Drs. Hussein Tawbi and Kurt Weiss with UPMC Hillman Cancer Center, chaired a start-up committee of 12 members who joined with the Sarcoma Foundation of America to fundraise and raise awareness for the Pittsburgh area and beyond. The group pursued a 5K event with a goal to raise awareness and support others who have been affected by this rare cancer. This event, along with the creation of the website, garnered much attention in the Pittsburgh region and gathered many families who have been affected by sarcoma cancer.
The overwhelming success of the initial 5K fundraiser in 2011 set the foundation for this to be an annual event, which has continued to grow each year in participation and funding to support research. To date this event, as well as an annual golf outing, has raised over $1,000,00,000 to support sarcoma research here in Pittsburgh and across the nation through the Sarcoma Foundation of America (SFA). Since 2012, the SFA has presented a research grant named in honor of Pittsburgh Cure Sarcoma to a sarcoma researcher in the United States to continue efforts to development innovative treatment approaches for sarcoma. This would not be possible without the support and participation of major sponsors in the Pittsburgh region and involvement of generous patients and their families.
Please join us to help ensure that our progress to support sarcoma research continues.